Protective effects of monoclonal antibodies and immunopurified glycoproteins in primary HSV-1 infection.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000914:Antibodies, Viral / Q000276:immunology; D000917:Antibody Formation; D000918:Antibody Specificity; D002846:Chromatography, Affinity; D006023:Glycoproteins / Q000276:immunology / Q000302:isolation & purification; D006561:Herpes Simplex / Q000517:prevention & control / Q000628:therapy*; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007114:Immunization; D007167:Immunotherapy; D051379:Mice; D009500:Neutralization Tests; D018139:Simplexvirus / Q000276:immunology*; D014764:Viral Proteins / Q000276:immunology / Q000302:isolation & purification
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D006023:Glycoproteins; D014764:Viral Proteins